Eintrag weiter verarbeiten
EGFRAmplification and Glioblastoma Stem-Like Cells
Gespeichert in:
Zeitschriftentitel: | Stem Cells International |
---|---|
Personen und Körperschaften: | , , |
In: | Stem Cells International, 2015, 2015, S. 1-11 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Hindawi Limited
|
Schlagwörter: |
author_facet |
Liffers, Katrin Lamszus, Katrin Schulte, Alexander Liffers, Katrin Lamszus, Katrin Schulte, Alexander |
---|---|
author |
Liffers, Katrin Lamszus, Katrin Schulte, Alexander |
spellingShingle |
Liffers, Katrin Lamszus, Katrin Schulte, Alexander Stem Cells International EGFRAmplification and Glioblastoma Stem-Like Cells Cell Biology Molecular Biology |
author_sort |
liffers, katrin |
spelling |
Liffers, Katrin Lamszus, Katrin Schulte, Alexander 1687-966X 1687-9678 Hindawi Limited Cell Biology Molecular Biology http://dx.doi.org/10.1155/2015/427518 <jats:p>Glioblastoma (GBM), the most common malignant brain tumor in adults, contains a subpopulation of cells with a stem-like phenotype (GS-cells). GS-cells can be maintained<jats:italic>in vitro</jats:italic>using serum-free medium supplemented with epidermal growth factor, basic fibroblast growth factor-2, and heparin. However, this method does not conserve amplification of the Epidermal Growth Factor Receptor (<jats:italic>EGFR</jats:italic>) gene, which is present in over 50% of all newly diagnosed GBM cases. GS-cells with retained<jats:italic>EGFR</jats:italic>amplification could overcome the limitations of current<jats:italic>in vitro</jats:italic>model systems and contribute significantly to preclinical research on EGFR-targeted therapy. This review recapitulates recent methodological approaches to expand stem-like cells from GBM with different<jats:italic>EGFR</jats:italic>status in order to maintain EGFR-dependent intratumoral heterogeneity<jats:italic>in vitro</jats:italic>. Further, it will summarize the current knowledge about the impact of<jats:italic>EGFR</jats:italic>amplification and overexpression on the stem-like phenotype of GBM-derived GS-cells and different approaches to target the EGFR-dependent GS-cell compartment of GBM.</jats:p> <i>EGFR</i>Amplification and Glioblastoma Stem-Like Cells Stem Cells International |
doi_str_mv |
10.1155/2015/427518 |
facet_avail |
Online Free |
finc_class_facet |
Biologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzQyNzUxOA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzQyNzUxOA |
institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
imprint |
Hindawi Limited, 2015 |
imprint_str_mv |
Hindawi Limited, 2015 |
issn |
1687-966X 1687-9678 |
issn_str_mv |
1687-966X 1687-9678 |
language |
English |
mega_collection |
Hindawi Limited (CrossRef) |
match_str |
liffers2015egframplificationandglioblastomastemlikecells |
publishDateSort |
2015 |
publisher |
Hindawi Limited |
recordtype |
ai |
record_format |
ai |
series |
Stem Cells International |
source_id |
49 |
title |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_unstemmed |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_full |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_fullStr |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_full_unstemmed |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_short |
EGFRAmplification and Glioblastoma Stem-Like Cells |
title_sort |
<i>egfr</i>amplification and glioblastoma stem-like cells |
topic |
Cell Biology Molecular Biology |
url |
http://dx.doi.org/10.1155/2015/427518 |
publishDate |
2015 |
physical |
1-11 |
description |
<jats:p>Glioblastoma (GBM), the most common malignant brain tumor in adults, contains a subpopulation of cells with a stem-like phenotype (GS-cells). GS-cells can be maintained<jats:italic>in vitro</jats:italic>using serum-free medium supplemented with epidermal growth factor, basic fibroblast growth factor-2, and heparin. However, this method does not conserve amplification of the Epidermal Growth Factor Receptor (<jats:italic>EGFR</jats:italic>) gene, which is present in over 50% of all newly diagnosed GBM cases. GS-cells with retained<jats:italic>EGFR</jats:italic>amplification could overcome the limitations of current<jats:italic>in vitro</jats:italic>model systems and contribute significantly to preclinical research on EGFR-targeted therapy. This review recapitulates recent methodological approaches to expand stem-like cells from GBM with different<jats:italic>EGFR</jats:italic>status in order to maintain EGFR-dependent intratumoral heterogeneity<jats:italic>in vitro</jats:italic>. Further, it will summarize the current knowledge about the impact of<jats:italic>EGFR</jats:italic>amplification and overexpression on the stem-like phenotype of GBM-derived GS-cells and different approaches to target the EGFR-dependent GS-cell compartment of GBM.</jats:p> |
container_start_page |
1 |
container_title |
Stem Cells International |
container_volume |
2015 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792338998774988800 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:41:09.216Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=EGFRAmplification+and+Glioblastoma+Stem-Like+Cells&rft.date=2015-01-01&genre=article&issn=1687-9678&volume=2015&spage=1&epage=11&pages=1-11&jtitle=Stem+Cells+International&atitle=%3Ci%3EEGFR%3C%2Fi%3EAmplification+and+Glioblastoma+Stem-Like+Cells&aulast=Schulte&aufirst=Alexander&rft_id=info%3Adoi%2F10.1155%2F2015%2F427518&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792338998774988800 |
author | Liffers, Katrin, Lamszus, Katrin, Schulte, Alexander |
author_facet | Liffers, Katrin, Lamszus, Katrin, Schulte, Alexander, Liffers, Katrin, Lamszus, Katrin, Schulte, Alexander |
author_sort | liffers, katrin |
container_start_page | 1 |
container_title | Stem Cells International |
container_volume | 2015 |
description | <jats:p>Glioblastoma (GBM), the most common malignant brain tumor in adults, contains a subpopulation of cells with a stem-like phenotype (GS-cells). GS-cells can be maintained<jats:italic>in vitro</jats:italic>using serum-free medium supplemented with epidermal growth factor, basic fibroblast growth factor-2, and heparin. However, this method does not conserve amplification of the Epidermal Growth Factor Receptor (<jats:italic>EGFR</jats:italic>) gene, which is present in over 50% of all newly diagnosed GBM cases. GS-cells with retained<jats:italic>EGFR</jats:italic>amplification could overcome the limitations of current<jats:italic>in vitro</jats:italic>model systems and contribute significantly to preclinical research on EGFR-targeted therapy. This review recapitulates recent methodological approaches to expand stem-like cells from GBM with different<jats:italic>EGFR</jats:italic>status in order to maintain EGFR-dependent intratumoral heterogeneity<jats:italic>in vitro</jats:italic>. Further, it will summarize the current knowledge about the impact of<jats:italic>EGFR</jats:italic>amplification and overexpression on the stem-like phenotype of GBM-derived GS-cells and different approaches to target the EGFR-dependent GS-cell compartment of GBM.</jats:p> |
doi_str_mv | 10.1155/2015/427518 |
facet_avail | Online, Free |
finc_class_facet | Biologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE1LzQyNzUxOA |
imprint | Hindawi Limited, 2015 |
imprint_str_mv | Hindawi Limited, 2015 |
institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
issn | 1687-966X, 1687-9678 |
issn_str_mv | 1687-966X, 1687-9678 |
language | English |
last_indexed | 2024-03-01T15:41:09.216Z |
match_str | liffers2015egframplificationandglioblastomastemlikecells |
mega_collection | Hindawi Limited (CrossRef) |
physical | 1-11 |
publishDate | 2015 |
publishDateSort | 2015 |
publisher | Hindawi Limited |
record_format | ai |
recordtype | ai |
series | Stem Cells International |
source_id | 49 |
spelling | Liffers, Katrin Lamszus, Katrin Schulte, Alexander 1687-966X 1687-9678 Hindawi Limited Cell Biology Molecular Biology http://dx.doi.org/10.1155/2015/427518 <jats:p>Glioblastoma (GBM), the most common malignant brain tumor in adults, contains a subpopulation of cells with a stem-like phenotype (GS-cells). GS-cells can be maintained<jats:italic>in vitro</jats:italic>using serum-free medium supplemented with epidermal growth factor, basic fibroblast growth factor-2, and heparin. However, this method does not conserve amplification of the Epidermal Growth Factor Receptor (<jats:italic>EGFR</jats:italic>) gene, which is present in over 50% of all newly diagnosed GBM cases. GS-cells with retained<jats:italic>EGFR</jats:italic>amplification could overcome the limitations of current<jats:italic>in vitro</jats:italic>model systems and contribute significantly to preclinical research on EGFR-targeted therapy. This review recapitulates recent methodological approaches to expand stem-like cells from GBM with different<jats:italic>EGFR</jats:italic>status in order to maintain EGFR-dependent intratumoral heterogeneity<jats:italic>in vitro</jats:italic>. Further, it will summarize the current knowledge about the impact of<jats:italic>EGFR</jats:italic>amplification and overexpression on the stem-like phenotype of GBM-derived GS-cells and different approaches to target the EGFR-dependent GS-cell compartment of GBM.</jats:p> <i>EGFR</i>Amplification and Glioblastoma Stem-Like Cells Stem Cells International |
spellingShingle | Liffers, Katrin, Lamszus, Katrin, Schulte, Alexander, Stem Cells International, EGFRAmplification and Glioblastoma Stem-Like Cells, Cell Biology, Molecular Biology |
title | EGFRAmplification and Glioblastoma Stem-Like Cells |
title_full | EGFRAmplification and Glioblastoma Stem-Like Cells |
title_fullStr | EGFRAmplification and Glioblastoma Stem-Like Cells |
title_full_unstemmed | EGFRAmplification and Glioblastoma Stem-Like Cells |
title_short | EGFRAmplification and Glioblastoma Stem-Like Cells |
title_sort | <i>egfr</i>amplification and glioblastoma stem-like cells |
title_unstemmed | EGFRAmplification and Glioblastoma Stem-Like Cells |
topic | Cell Biology, Molecular Biology |
url | http://dx.doi.org/10.1155/2015/427518 |